Results 51 to 60 of about 354,280 (226)

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

open access: yesMolecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic   +5 more
wiley   +1 more source

ER(R)GO nr 36 (1/2018) - utopias/illusion/longings (guest edited by Beata Wojewoda)

open access: yes, 2018
Full text of ER(R)GO nr 36 (1/2018) - utopias/illusion/longings (guest edited by Beata Wojewoda)The complete issue of ER(R)GO nr 36 (1/2018) - utopie/iluzje/pragnienia (guest edited by Beata ...
Er(r)go, Redakcja
core  

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation

open access: yesMolecular Oncology, EarlyView.
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova   +14 more
wiley   +1 more source

ER(R)GO nr 36 (1/2018) - utopie/iluzje/pragnienia (pod redakcją gościnną Beaty Wojewody)

open access: yes, 2018
Full text of ER(R)GO nr 36 (1/2018) - utopias/illusion/longings (guest edited by Beata Wojewoda)The complete issue of ER(R)GO nr 36 (1/2018) - utopie/iluzje/pragnienia (guest edited by Beata ...
Er(r)go, Redakcja
core  

Informacje dla Autorów

open access: yes, 2020
Info for the Contributors to Er(r)go and the journal\u27s stylesheet.Informacje dla Autorów i karta stylu "Er(r)go"
Er(r)go, Redakcja
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Information for Contributors

open access: yes, 2020
Info for the Contributors to Er(r)go and the journal's stylesheet.Informacje dla ...
Er(r)go, Redakcja
core   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

ER(R)GO nr 38 (1/2019) - dyskursy weg(etari)anizmu

open access: yes, 2019
The full issue of ER(R)GO No.
Er(r)go, Redakcja w
core  

Home - About - Disclaimer - Privacy